XML 70 R52.htm IDEA: XBRL DOCUMENT v3.20.4
Revenue - Reimbursement of R and D Costs (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Research and Development Reimbursement      
Total reduction to R and D expense $ 10,078 $ 5,589 $ 9,112
Janssen      
Research and Development Reimbursement      
Total reduction to R and D expense 8,554 5,129 1,597
Viatris      
Research and Development Reimbursement      
Total reduction to R and D expense $ 1,524 $ 460 $ 7,515